NOVEL SYNTHETIC APPROACHES TO ANTITUMOR COMPOUNDS: ANTIVIRALS, HIV

抗肿瘤化合物的新合成方法：抗病毒药物、HIV

• 批准号: 7601801
• 负责人: BARRY M TROST
• 金额: $ 19.36万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-09-30 至 2008-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7601801
• 关键词: Alkaloids; Antiviral Agents; Class; Computer Retrieval of Information on Scientific Projects Database; Development; Funding; Grant; Institution; Research; Research Personnel; Resources; Source; Terpenes; United States National Institutes of Health; analog; novel; programs

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The program involves the development of synthetic strategies to compounds of known antitumor activity to generate structurally related but inaccessible analogues. Compounds of many different classes, including alkaloids, terpenoids, and polyacetates are being examined.

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 该计划涉及开发已知抗肿瘤活性的化合物的合成策略，以生成结构相关但难以获得的类似物。 许多不同类别的化合物，包括生物碱，萜类化合物和聚乙酸酯正在研究中。